Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID-19 (Review)

The cytokine storm from the evolution of severe cases of COVID-19, requiring strong immunosuppressive therapies, has raised the issue of reactivation of hepatitis B virus (HBV) infections in these patients. An analysis of the first observational studies in patients with COVID-19 and immunosuppressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Baroiu, Liliana, Anghel, Lucreția, Laurențiu Tatu, Alin, Iancu, Alina Viorica, Dumitru, Caterina, Leșe, Ana-Cristina, Drăgănescu, Miruna, Năstase, Florentina, Niculeț, Elena, Fotea, Silvia, Nechita, Aurel, Voinescu, Doina Carina, Stefanopol, Anca Ioana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019722/
https://www.ncbi.nlm.nih.gov/pubmed/35495599
http://dx.doi.org/10.3892/etm.2022.11312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019722/
https://www.ncbi.nlm.nih.gov/pubmed/35495599
http://dx.doi.org/10.3892/etm.2022.11312

Ejemplares similares